News

Autorisation de l’ANSM à mettre sur le marché le réactif UltraGene Assay SARS-CoV-2 452R & 484K & 484Q Mutations

Autorisation de mise sur le marché du dispositif UltraGene Assay SARS-CoV-2 452R & 484K & 484Q Mutations Nous avons le plaisir d’annoncer la disponibilité immédiate* du dispositif médical UltraGene Assay SARS-CoV-2 452R & 484K & 484Q Mutations, permettant, par amplification gén…

Advanced Biological Laboratories (ABL) S.A. and An Binh Medical are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Vietnam. See current channel partners.

SARS-CoV-2 Genotyping using Next Generation Sequencing (NGS) Now Suited to Small, Medium and High-throughput Clinical Settings. Advanced Biological Laboratories (ABL) announced today the CE-IVD registration of its DeepChek® Whole Genome SARS-CoV-2 Genotyping Assay, the first in-vitro diagnostics kit…

Première région touchée par la pandémie, le Grand Est est également la première région qui a mobilisé avec succès, depuis le début de la crise sanitaire, l’intégralité de son écosystème santé avec le soutien du pôle de compétitivité BioValley France. La COVID-19 nous prouve aujourd’hui que le dévelo…

You are a new Client ? This offer is made for you !! Get your free sample kit among all our microbiology genotyping assays  (SANGER or Next Generation Sequencing)                                   Offer Available Un…

Advanced Biological Laboratories (ABL) S.A. and Roche Diagnostics are pleased to announce that they entered into an exclusive distribution agreement of ABL’s Diagnostics line of products, including the DeepChek® Assays and software, in Portugal. See current channel partners.

Advanced Biological Laboratories (ABL) announced today the CE-IVD registration of its UltraGene® SARS-CoV-2 Triplex Assay, now available for in-vitro diagnostics use. This innovative test is a real-time RT-PCR test intended for the qualitative detection of RNA from the SARS-CoV-2and genomic variatio…

ABL is pleased to announce today that the UltraGene Assay SARS-CoV-2 Multi Variants Deletions V1, a direct qPCR assay to be used on already SARS-CoV-2 positive samples (no need to do additional RNA isolation), received CE-IVD Marking. The kit, targeting 5 different genomic variations on 3 genes in a…

For more information please contact us at the following email address: contact@ablsa.com  

ABL is pleased to share with you that the UltraGene qPCR SARS-CoV-2 Multi Variants Deletions Assay (RUO), a direct qPCR assay to be used on already SARS-CoV-2 positive samples (no need to do additional RNA isolation), is now available. The kit, targeting 5 different genomic variations on 3 genes in…

We are pleased to announce the immediate availability of Safe, Scalable, Simple, Soft and Stable saliva collection kits, CE-IVD marked, to help you with you saliva sampling projects.   For more information please contact us at the following email address: contact@ablsa.com

New Kit & Software for SARS-CoV-2 Whole Genome Sequencing

We are pleased to announce the immediate availability of the DeepChek® Assay Whole Genome SARS-CoV-2 Genotyping V1 and the DeepChek® CoV2 Software. Both combined, it offers an innovative end-to-end solution (for Research Use Only (RUO)) for SARS-CoV-2 whole genome sequencing and analysis: from SARS-…

Immediate availability (<72 hours) of high-quality & cost effective specimen collection kits: Various collection method… Nasopharyngeal Swab Oropharyngeal Swab Saliva Collection Kit …combined with High-quality VTM CE IVD Virus INACTIVATION RNA/DNA PRESERVATION up to 7 days at room…

We are pleased to announce the immediate availability of the UltraGene Assay SARS-CoV-2 N / Spike Δ 69-70, a direct qPCR assay to be used on already SARS-CoV-2 positive samples (no need to do additional RNA isolation) to screen the SARS-CoV-2 Spike protein 69-70 amino-acid deletion, synonymous of th…

We are pleased to announce the immediate availability of genotyping products for discovering and developing medical knowledge related to SARS-CoV-2 “UK” and “South African” Strains through Next Generation Sequencing (NGS) and COVID-19 specialized bio-IT pipeline. DeepChek® 8-plex CoV-2 Genotyping As…